Roger Klein, MD, JD, part ii, Are we Spiraling to the Bottom? - Episode 3
Are we spiraling to the bottom? Is there any hope for value-based pricing in diagnostics? Roger D. Klein MD, JD, FCAP is a former HHS Advisor to FDA, CMS and CDC, and the immediate past chair of the Association for Molecular Pathology (AMP) Solid Tumors Division. A physician and an attorney, Dr Klein served as an expert and key spokesperson in the lawsuit “Association for Molecular Pathology v. Myriad Genetics, Inc.” in which the U.S. Supreme Court invalidated patents on breast cancer genes. He is a leading authority on public policies related to the implementation of precision medicine.
